Eli Lilly Sees New Weight-Loss Pill Approval in Early 2026
January 13, 2025
2,800
34
2
1.29%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Bloomberg News Episodes Around January 13, 2025
See what was published immediately before and after this episode.
0:45Now PlayingEli Lilly Sees New Weight-Loss Pill Approval in Early 2026
YouTube Description
as posted by the channelEli Lilly & Co. is projecting approval of its experimental weight-loss pill as soon as early 2026, Chief Executive Officer Dave Ricks said, one of several in a new generation of the popular drugs.
Lilly expects data on the pill, called orforglipron, to arrive before the middle of 2025, which could lead to clearance early the following year, Ricks said in an interview with Bloomberg TV at the JPMorgan Healthcare Conference in San Francisco.
--------
Subscribe to our YouTube channel
Subscribe to Bloomberg Originals
Bloomberg Quicktake brings you global social video spanning business, technology, politics and culture. Make sense of the stories changing your business and your world.
Connect with us on…
Breaking News on YouTube
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.